Tigran Aivazian

Title: Tigran Aivazian: Innovator in Immunology

Introduction

Tigran Aivazian is a notable inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly through his innovative work on BTLA fusion protein agonists. With a total of three patents to his name, Aivazian's research has the potential to impact the treatment of various diseases.

Latest Patents

Aivazian's latest patents focus on BTLA fusion protein agonists and their uses. The present invention is based on the seminal discovery that BTLA agonist fusion proteins modulate an immune response. Specifically, the invention provides fusion proteins that bind BTLA, enhancing BTLA signaling. Furthermore, it outlines methods for treating cancer and immune and inflammatory diseases and disorders using a BTLA agonist fusion protein.

Career Highlights

Throughout his career, Tigran Aivazian has worked with prestigious organizations, including Sanford Burnham Prebys Medical Discovery Institute and Pfizer Corporation. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Aivazian has collaborated with notable colleagues, including Brian Miller and Carl F. Ware. These partnerships have enriched his research and expanded the scope of his innovations.

Conclusion

Tigran Aivazian is a prominent figure in the field of immunology, with a focus on BTLA fusion protein agonists. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work holds promise for the future of cancer treatment and immune system disorders.